Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study
Crossref DOI link: https://doi.org/10.1186/s12879-016-1965-5
Published Online: 2016-11-07
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Beran, Jiří https://orcid.org/0000-0002-5119-4197
Šalapová, Eva
Špajdel, Marian
License valid from 2016-11-07
